Large-scale testing (Phase 3)Study completedNCT01040052What this trial is testingAssess the Safety of Adacel® VaccineWho this might be right forDiphtheriaTetanusPertussis Sanofi Pasteur, a Sanofi Company 30
Not applicableStudy completedNCT01560832What this trial is testingDescriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific RegionWho this might be right forClostridium Difficile Infection Yonsei University 188
Early research (Phase 1)Study completedNCT02981316What this trial is testingTreatment of Recurrent Clostridium Difficile Infection With RBX7455Who this might be right forClostridium Difficile Infection Mayo Clinic 30
Not applicableStudy completedNCT03931239What this trial is testingThe Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 WeeksWho this might be right forDiphtheriaTetanusPertussis+2 more Vabiotech 222
Large-scale testing (Phase 3)Study completedNCT00314951What this trial is testingFidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)Who this might be right forClostridium InfectionsDiarrhea Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Not applicableStudy completedNCT07444502What this trial is testingSafety Monitoring of Boostagen® Vaccine in ThailandWho this might be right forPertussis (Whooping Cough)TetanusDiphtheria BioNet-Asia Co., Ltd. 10,727
Not applicableEnded earlyNCT01533844What this trial is testingTo Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the PathogenesisWho this might be right forClostridium Difficile Astellas Pharma Europe B.V. 1
Not applicableStudy completedNCT05835219What this trial is testingREBYOTA™ Prospective RegistryWho this might be right forRecurrence of Clostridium Difficile Infection Ferring Pharmaceuticals 145
Not applicableStudy completedNCT02573571What this trial is testingPersonalized Needs in Clostridium Difficile InfectionsWho this might be right forBiologic MarkersClinical Markers University of Athens 150
Not applicableNot Yet RecruitingNCT07446166What this trial is testingTETANUS Antibody Detection in Saliva StudyWho this might be right forTetanus University of Birmingham 390
Post-approval studies (Phase 4)Study completedNCT02692651What this trial is testingA Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent InfectionsWho this might be right forClostridium Difficile Infection (CDI) University of Michigan 144
Testing effectiveness (Phase 2)Study completedNCT01701999What this trial is testingSafety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum ToxoidWho this might be right forBotulism California Department of Public Health 45
Very early researchWithdrawnNCT04246151What this trial is testingOral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized PatientsWho this might be right forClostridium Difficile ColonizationClostridium Difficile Diarrhea Hamilton Health Sciences Corporation
Testing effectiveness (Phase 2)Ended earlyNCT03548051What this trial is testingSafety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)Who this might be right forClostridial InfectionDysbiosisProbiotic Therapy National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Study completedNCT00109330What this trial is testingA Combined Tdap Vaccine Used As A Booster Compared To Licensed Td VaccineWho this might be right forDiphtheriaTetanusAcellular Pertussis GlaxoSmithKline 4,116
Post-approval studies (Phase 4)Temporarily pausedNCT00591357What this trial is testingEfficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic TherapyWho this might be right forAntibiotic-Associated DiarrheaClostridium Difficile Michael E. DeBakey VA Medical Center 120
Large-scale testing (Phase 3)Study completedNCT06708286What this trial is testingA Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)Who this might be right forDiphtheriaTetanusPertussis CanSino Biologics Inc. 1,820
Early research (Phase 1)Enrolling By InvitationNCT01868373What this trial is testingDefined Fecal Microbiota Transplantation for Clostridium Difficile DiarrheaWho this might be right forActive C. Difficile Colitis Baylor College of Medicine 12
Post-approval studies (Phase 4)Study completedNCT00514059What this trial is testingImmunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccineWho this might be right forDiphtheriaTetanusPertussis+1 more Norwegian Institute of Public Health 83
Large-scale testing (Phase 3)Study completedNCT01249183What this trial is testingSafety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldWho this might be right forDiphtheriaTetanusPertussis+1 more Sanofi Pasteur, a Sanofi Company 954